Patients receiving Anastro cell had a decrease in hot flushes, vaginal bleeding, vaginal discharge, endometrial cancer, venous thromboembolic events including deep venous thrombosis and ischaemic cerebrovascular events compared with patients receiving tamoxifen doxycycline with azithromycin Most studies found no differences between tamoxifen and aromatase inhibitor groups in terms of global QOL

Опубликовано: 21.11.2022


* Ваше имя:
* Сообщение:
* Секретный код: CAPTCHA
* Введите секретный код:

Возврат к списку